Artivion Completes Acquisition of Endospan Ltd.
Artivion has completed its acquisition of Endospan Ltd., a pioneer in endovascular repair of aortic arch disease, for an upfront net purchase price of $135 million. The transaction was funded using a previously drawn $150 million delayed draw term loan, avoiding the need for new dilutive equity financing or additional debt issuance at closing.
Key figures
- Deal Value Usd
- 135000000
- Financing amount
- 150000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.